The primary analysis of efficacy was based on the intention-to-treat (ITT) population
(patients who received at least one dose of medication and had at least one post-baseline seizure frequency assessment), and supportive analyses were performed using the perprotocol(PP) population (all patients who completed the maintenance period without major protocol violations).